Titre : Myocytes cardiaques

Myocytes cardiaques : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Myocytes cardiaques : Questions médicales les plus fréquentes", "headline": "Myocytes cardiaques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Myocytes cardiaques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-14", "dateModified": "2026-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Myocytes cardiaques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cellules musculaires", "url": "https://questionsmedicales.fr/mesh/D032342", "about": { "@type": "MedicalCondition", "name": "Cellules musculaires", "code": { "@type": "MedicalCode", "code": "D032342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.620" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Myofibrilles", "alternateName": "Myofibrils", "url": "https://questionsmedicales.fr/mesh/D009210", "about": { "@type": "MedicalCondition", "name": "Myofibrilles", "code": { "@type": "MedicalCode", "code": "D009210", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.620.500.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sarcomères", "alternateName": "Sarcomeres", "url": "https://questionsmedicales.fr/mesh/D012518", "about": { "@type": "MedicalCondition", "name": "Sarcomères", "code": { "@type": "MedicalCode", "code": "D012518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.620.500.500.700" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Myocytes cardiaques", "alternateName": "Myocytes, Cardiac", "code": { "@type": "MedicalCode", "code": "D032383", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Robert D Harvey", "url": "https://questionsmedicales.fr/author/Robert%20D%20Harvey", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, University of Nevada, Reno, Reno, NV 89557, United States of America. Electronic address: rdharvey@med.unr.edu." } }, { "@type": "Person", "name": "Cecilia Ferrantini", "url": "https://questionsmedicales.fr/author/Cecilia%20Ferrantini", "affiliation": { "@type": "Organization", "name": "Laboratory of Non-Linear Spectroscopy (LENS), University of Florence, Sesto Fiorentino, Italy." } }, { "@type": "Person", "name": "Francesco S Pavone", "url": "https://questionsmedicales.fr/author/Francesco%20S%20Pavone", "affiliation": { "@type": "Organization", "name": "Laboratory of Non-Linear Spectroscopy (LENS), University of Florence, Sesto Fiorentino, Italy." } }, { "@type": "Person", "name": "Corrado Poggesi", "url": "https://questionsmedicales.fr/author/Corrado%20Poggesi", "affiliation": { "@type": "Organization", "name": "Division of Physiology, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy." } }, { "@type": "Person", "name": "Leonardo Sacconi", "url": "https://questionsmedicales.fr/author/Leonardo%20Sacconi", "affiliation": { "@type": "Organization", "name": "Laboratory of Non-Linear Spectroscopy (LENS), University of Florence, Sesto Fiorentino, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Enhancing Origin Prediction: Deep Learning Model for Diagnosing Premature Ventricular Contractions with Dual-Rhythm Analysis Focused on Cardiac Rotation.", "datePublished": "2024-09-13", "url": "https://questionsmedicales.fr/article/39271126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/europace/euae240" } }, { "@type": "ScholarlyArticle", "name": "Clinicians' experience of barriers and facilitators to care delivery of an extracorporeal cardiopulmonary resuscitation service for out-of-hospital cardiac arrest: a qualitative survey.", "datePublished": "2024-09-13", "url": "https://questionsmedicales.fr/article/39272171", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13049-024-01261-7" } }, { "@type": "ScholarlyArticle", "name": "Mean arterial pressure versus cardiac index for haemodynamic management and myocardial injury after hepatopancreatic surgery: A randomised controlled trial.", "datePublished": "2024-09-12", "url": "https://questionsmedicales.fr/article/39262319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/EJA.0000000000002059" } }, { "@type": "ScholarlyArticle", "name": "Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions.", "datePublished": "2024-09-12", "url": "https://questionsmedicales.fr/article/39328831", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fphys.2024.1475152" } }, { "@type": "ScholarlyArticle", "name": "Akkermansia Muciniphila supplementation improving hyperlipidemia, cardiac function, and gut microbiota in high fat fed apolipoprotein E-deficient mice.", "datePublished": "2024-09-10", "url": "https://questionsmedicales.fr/article/39265779", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.prostaglandins.2024.106906" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Cellules musculaires", "item": "https://questionsmedicales.fr/mesh/D032342" }, { "@type": "ListItem", "position": 4, "name": "Myocytes cardiaques", "item": "https://questionsmedicales.fr/mesh/D032383" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Myocytes cardiaques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Myocytes cardiaques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-04-29", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Myocytes cardiaques", "description": "Comment diagnostiquer une dysfonction des myocytes cardiaques ?\nQuels tests sanguins sont utiles pour les myocytes cardiaques ?\nQuels signes indiquent une atteinte des myocytes cardiaques ?\nQuelle imagerie est recommandée pour les myocytes cardiaques ?\nComment évaluer la viabilité des myocytes cardiaques ?", "url": "https://questionsmedicales.fr/mesh/D032383?page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Myocytes cardiaques", "description": "Quels symptômes indiquent une défaillance des myocytes cardiaques ?\nComment se manifeste une cardiomyopathie ?\nQuels signes d'alerte pour les myocytes cardiaques ?\nLes myocytes cardiaques affectent-ils la circulation sanguine ?\nQuels symptômes d'arythmie cardiaque ?", "url": "https://questionsmedicales.fr/mesh/D032383?page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Myocytes cardiaques", "description": "Comment prévenir les maladies des myocytes cardiaques ?\nLe tabagisme affecte-t-il les myocytes cardiaques ?\nL'hypertension influence-t-elle les myocytes ?\nLe stress a-t-il un impact sur le cœur ?\nComment le diabète influence-t-il les myocytes ?", "url": "https://questionsmedicales.fr/mesh/D032383?page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Myocytes cardiaques", "description": "Quels médicaments pour traiter les myocytes cardiaques ?\nComment la rééducation cardiaque aide-t-elle ?\nQuand envisager une intervention chirurgicale ?\nQuels traitements non médicamenteux existent ?\nLes dispositifs implantables sont-ils utiles ?", "url": "https://questionsmedicales.fr/mesh/D032383?page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Myocytes cardiaques", "description": "Quelles complications peuvent survenir avec des myocytes cardiaques endommagés ?\nLes myocytes cardiaques affectent-ils la circulation ?\nComment les myocytes cardiaques influencent-ils le rythme cardiaque ?\nQuelles sont les conséquences d'une cardiomyopathie ?\nLes myocytes cardiaques peuvent-ils se régénérer ?", "url": "https://questionsmedicales.fr/mesh/D032383?page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Myocytes cardiaques", "description": "Quels sont les principaux facteurs de risque pour les myocytes cardiaques ?\nL'âge influence-t-il la santé des myocytes cardiaques ?\nLe cholestérol affecte-t-il les myocytes cardiaques ?\nLe stress psychologique est-il un facteur de risque ?\nL'inactivité physique influence-t-elle les myocytes ?", "url": "https://questionsmedicales.fr/mesh/D032383?page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des myocytes cardiaques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un électrocardiogramme (ECG) et une échocardiographie sont utilisés pour évaluer la fonction cardiaque." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles pour les myocytes cardiaques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de troponine et de BNP aident à évaluer les lésions cardiaques et l'insuffisance cardiaque." } }, { "@type": "Question", "name": "Quels signes indiquent une atteinte des myocytes cardiaques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, essoufflement et fatigue peuvent signaler une atteinte myocytaire." } }, { "@type": "Question", "name": "Quelle imagerie est recommandée pour les myocytes cardiaques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM cardiaque permet d'évaluer la structure et la fonction des myocytes cardiaques." } }, { "@type": "Question", "name": "Comment évaluer la viabilité des myocytes cardiaques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un test de stress cardiaque peut aider à évaluer la viabilité et la fonction des myocytes." } }, { "@type": "Question", "name": "Quels symptômes indiquent une défaillance des myocytes cardiaques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, essoufflement, œdème et palpitations." } }, { "@type": "Question", "name": "Comment se manifeste une cardiomyopathie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs thoraciques, essoufflement et arythmies." } }, { "@type": "Question", "name": "Quels signes d'alerte pour les myocytes cardiaques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques sévères et une sudation excessive peuvent être alarmants." } }, { "@type": "Question", "name": "Les myocytes cardiaques affectent-ils la circulation sanguine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une défaillance des myocytes peut entraîner une mauvaise circulation sanguine." } }, { "@type": "Question", "name": "Quels symptômes d'arythmie cardiaque ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les arythmies peuvent provoquer des palpitations, des étourdissements et des évanouissements." } }, { "@type": "Question", "name": "Comment prévenir les maladies des myocytes cardiaques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il les myocytes cardiaques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de maladies cardiaques et affecte les myocytes." } }, { "@type": "Question", "name": "L'hypertension influence-t-elle les myocytes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hypertension peut endommager les myocytes cardiaques et entraîner des complications." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le cœur ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la santé cardiaque et la fonction des myocytes." } }, { "@type": "Question", "name": "Comment le diabète influence-t-il les myocytes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète peut entraîner des lésions des myocytes cardiaques, augmentant le risque de maladies." } }, { "@type": "Question", "name": "Quels médicaments pour traiter les myocytes cardiaques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les bêtabloquants et les inhibiteurs de l'ECA sont couramment utilisés pour traiter les dysfonctions." } }, { "@type": "Question", "name": "Comment la rééducation cardiaque aide-t-elle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation cardiaque améliore la fonction cardiaque et la qualité de vie des patients." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie peut être nécessaire en cas de cardiomyopathie sévère ou d'arythmies résistantes." } }, { "@type": "Question", "name": "Quels traitements non médicamenteux existent ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des changements de mode de vie, comme l'exercice et une alimentation saine, sont recommandés." } }, { "@type": "Question", "name": "Les dispositifs implantables sont-ils utiles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les défibrillateurs implantables peuvent prévenir les arythmies potentiellement mortelles." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des myocytes cardiaques endommagés ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance cardiaque, les arythmies et les infarctus." } }, { "@type": "Question", "name": "Les myocytes cardiaques affectent-ils la circulation ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des myocytes endommagés peuvent entraîner une circulation sanguine inefficace." } }, { "@type": "Question", "name": "Comment les myocytes cardiaques influencent-ils le rythme cardiaque ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des myocytes dysfonctionnels peuvent provoquer des arythmies et des palpitations." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une cardiomyopathie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La cardiomyopathie peut entraîner une insuffisance cardiaque et des complications graves." } }, { "@type": "Question", "name": "Les myocytes cardiaques peuvent-ils se régénérer ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La régénération des myocytes cardiaques est limitée, ce qui complique la récupération." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les myocytes cardiaques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "L'âge influence-t-il la santé des myocytes cardiaques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de maladies cardiaques augmente avec l'âge en raison de la dégénérescence cellulaire." } }, { "@type": "Question", "name": "Le cholestérol affecte-t-il les myocytes cardiaques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un taux élevé de cholestérol peut entraîner des maladies coronariennes et affecter les myocytes." } }, { "@type": "Question", "name": "Le stress psychologique est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress psychologique peut contribuer à des problèmes cardiaques et affecter les myocytes." } }, { "@type": "Question", "name": "L'inactivité physique influence-t-elle les myocytes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le manque d'exercice augmente le risque de maladies cardiaques et affecte les myocytes." } } ] } ] }

Sources (10000 au total)

Enhancing Origin Prediction: Deep Learning Model for Diagnosing Premature Ventricular Contractions with Dual-Rhythm Analysis Focused on Cardiac Rotation.

Several algorithms can differentiate inferior axis premature ventricular contractions (PVCs) originating from the right side and left side on 12-lead electrocardiograms (ECGs). However, it is unclear ... We compared the Dual-Rhythm model (incorporating both SR and PVC) to the PVC model (using PVC alone), and quantified the contribution of each ECG lead in predicting the PVC origin for each cardiac rot... This multicenter study enrolled 593 patients from 11 centers-493 from Japan and Germany, and 100 from Belgium, which used as the external validation dataset. Using a hybrid approach combining a Resnet... In the external validation dataset, the Dual-Rhythm model outperformed the PVC model in accuracy (0.84 vs. 0.74, respectively; p < 0.01), precision (0.73 vs. 0.55, respectively; p < 0.01), specificity... Our deep learning-based model, incorporating both PVC and SR morphologies, resulted in a higher prediction accuracy for PVC origin. Considering SR is particularly important for predicting right-sided ...

Clinicians' experience of barriers and facilitators to care delivery of an extracorporeal cardiopulmonary resuscitation service for out-of-hospital cardiac arrest: a qualitative survey.

Out-of-hospital cardiac arrest (OHCA) survival in the UK remains overall poor with fewer than 10% of patients surviving to hospital discharge. Extracorporeal cardiopulmonary resuscitation (ECPR) is a ... In January 2023, Thames Valley Air Ambulance (TVAA) and Harefield Hospital developed an ECPR partnership pathway for conveyance of OHCA patients for in-hospital ECPR. The authors of this study conduct... Responses were received from 14 pre-hospital TVAA critical care and 9 in-hospital clinicians' representative of various roles and experiences. Data analysis revealed 10 key themes and 19 subthemes. Th... This study identified several clear themes and subthemes from clinical experience that should be considered when developing and modelling an ECPR system for OHCA. These insights may inform future deve...

Mean arterial pressure versus cardiac index for haemodynamic management and myocardial injury after hepatopancreatic surgery: A randomised controlled trial.

Myocardial injury after noncardiac surgery (MINS) frequently complicates the peri-operative period and is associated with increased mortality.... We hypothesised that cardiac index (CI) based haemodynamic management reduces peri-operative high-sensitive troponin-T (hsTnT) elevation and MINS incidence in patients undergoing hepatic/pancreatic su... A randomised controlled study.... A single-centre study conducted in a university-affiliated tertiary hospital between June 2022 and March 2023.... Ninety-one patients, who were ≥ 65 years old or ≥ 45 years old with a history of at least one cardiac risk factor were randomised to either mean arterial pressure (MAP) based (n = 45) or CI-based (n =... In group-MAP, patients received fluid boluses and/or a noradrenaline infusion to maintain MAP above the predefined threshold. In group-CI, patients received fluid boluses and/or dobutamine infusion to... The primary outcome was peri-operative hsTnT elevation. The secondary outcomes were MINS incidence and 90-day mortality.... The median absolute troponin elevation was 4.3 ng l-1 (95% CI 3.4 to 6) for the CI-based group, and 9.4 ng l-1 (95% CI 7.7 to 12.7) for the MAP-based group (median difference: 5.1 ng l-1, 95% CI 3 to ... CI-based haemodynamic management assures sufficient flow and consequently is associated with peri-operative hsTnT elevation and the incidence of MINS compared to MAP.... Clinicaltrials.gov identifier: NCT05391087....

Risk factors of cardiac arrest during a percutaneous coronary intervention performed with rotational atherectomy - analysis based on a Large National Registry.

Rotational atherectomy (RA) is traditionally administered for patients with heavily calcified lesions and is thereby characterized by a high risk of the performed intervention. However, the prevalence... Based on the data collected in the Polish Registry of Invasive Cardiology Procedures (ORPKI) from 2014 to 2021, we included 6522 patients who were treated with RA-assisted PCI. We scrutinized patient ... Thirty-five (0.5%) patients suffered from cardiac arrest during RA-PCI or preceding CA. They were characterized by significantly higher rates of prior stroke, acute coronary syndromes (ACS) as indicat... Severe clinical condition at baseline, expressed by ACS presence and Killip class IV, as well as RA-PCI performed within LMCA and other periprocedural complications, were the strongest predictors of c...

Immediate effects of upper limb exercises with and without deep breathing on lung function after cardiac surgery - a randomized crossover trial.

Open heart surgery, involving median sternotomy, may cause diminished chest wall motion and restrictive pulmonary function in the early postoperative period. Thoracic and upper extremity range of moti... In a randomized 2 × 2 crossover trial, 22 adult patients (> 18 years old) were assessed during one of the first days after surgery in the spring of 2022 at Örebro University Hospital, Sweden. Exercise... Both ROM-DB and ROM momentarily increased peripheral oxygen saturation (+ 1% ± 1, p = 0.004 and + 1% ± 1, p < 0.001, respectively), with no significant differences between these exercises (p = 0.525).... Upper limb elevations improved oxygenation momentarily, both performed with and without simultaneous deep breathing, with no significant differences between these exercises. The additive deep breathin... ClinicalTrials.gov (NCT05278819)....

Role of excessive mitochondrial fission in seawater immersion aggravated hemorrhagic shock-induced cardiac injury and the protective effect of Mdivi-1.

Seawater immersion significantly aggravated organ dysfunction following hemorrhagic shock, leading to higher mortality rate. However, the effective treatment are still unavailable in clinic. Mitochond... Mitochondrial fission protein dynamin-related protein 1 (Drp1) was activated and translocated from the cytoplasm to mitochondria in the heart following seawater immersion combined with hemorrhagic sho... Our findings indicate that Drp1-mediated mitochondrial fission could be a novel therapeutic targets for the treatment of seawater immersion combined with hemorrhagic shock.... Drp1 mitochondrial translocation played an important role in the cardiac dysfunction after seawater immersion combined with hemorrhage shock. Drp1-mediated excessive mitochondrial fission leads to car...